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Persistent High Incidence of 
Tuberculosis in Immigrants in 
a Low-Incidence Country 
Troels Lillebaek,* Åse B. Andersen,† Asger Dirksen,‡ Else Smith,* 
Lene T. Skovgaard,§ and Axel Kok-Jensen‡ 
Immigration from areas of high incidence is thought to have fueled the resurgence of tuberculosis (TB) in
areas of low incidence. To reduce the risk of disease in low-incidence areas, the main countermeasure has
been the screening of immigrants on arrival. This measure is based on the assumption of a prompt decline
in the incidence of TB in immigrants during their first few years of residence in a country with low overall
incidence. We have documented that this assumption is not true for 619 Somali immigrants reported in
Denmark as having TB. The annual incidence of TB declined only gradually during the first 7 years of res-
idence, from an initial 2,000 per 100,000 to 700 per 100,000. The decline was described by an exponential
function with a half-time of 5.7 (95% confidence interval 4.0 to 9.7) years. This finding seriously challenges
the adequacy of the customary practice of screening solely on arrival.
n most industrialized countries, the annual numbers of
cases and deaths caused by tuberculosis (TB) have steadily
declined over the past century up to the mid-1980s (1,2) (Fig-
ure 1). Since then, an increasing number of TB cases in immi-
grants has reversed this downward trend in countries that have
had substantial levels of immigration from areas with a high
prevalence of the disease (1,3,4) (Figure 2). Today, the propor-
tion of immigrants among persons reported as having TB
exceeds 50% in several European countries, including Den-
mark, Israel, the Netherlands, Norway, Sweden, and Switzer-
land (5). A similar proportion has been predicted for the
United States in 2002 (3). In Denmark, the doubling in
reported TB cases over the last 15 years has reflected, in large
measure, TB in immigrants from Somalia (6), who also
account for a sizeable proportion of TB cases in other Euro-
pean countries and North America (7–11).
The epidemiologic importance of migration for TB low-
incidence countries has been recognized for several years; the
main countermeasure has been the implementation of screen-
ing programs for immigrants at the time of arrival (4,12). In
1994, 20 of 23 European countries were reported to screen for
TB on immigrants’ arrival (4). This measure is based on the
fundamental assumption of a prompt decline in the incidence
of TB in immigrants from an area of high incidence during
their first few years of residence in the country of low inci-
dence. However, only a few studies have actually addressed
this question (13–17).
To evaluate the implications for the practice of screening
on arrival, we explored the changes with time of residence in
the incidence of TB in immigrants from high-incidence areas.
Our study focused on the 13,535 Somalis who arrived in Den-
mark during the 1990s, 901 of whom were subsequently
reported as having TB.
Methods
The study was designed as a nationwide retrospective
cohort analysis of surveillance data on all 901 Somalis
reported as having TB in Denmark from 1991 to 1999. In Den-
mark, TB reporting has been mandatory since 1905. Since
1922, all cultures for mycobacteria have been performed at the
International Reference Laboratory of Mycobacteriology at
Statens Serum Institut in Copenhagen (18). During the study
period, this laboratory provided bacteriologic data on all
Somalis reported in Denmark as having TB. TB treatment is
centralized in departments of respiratory, pediatric, and infec-
tious medicine, which are also responsible for reporting data
on all new and recurrent cases of TB by means of a standard-
ized form. These individual reports are collected in a national
surveillance register at the Department of Epidemiology at
Statens Serum Institut. This department provided information
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Figure 1. Cases of pulmonary tuberculosis in Denmark over a 125-year
period, based on national surveillance information: mortality rates and
incidence.RESEARCH
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on the annual number of cases, nationality of the patients, and
their date of entry into the country. The total number of Soma-
lis in Denmark at the end of each year was taken from the Sta-
tistical Yearbooks from 1992 to 2000, published in
Copenhagen by Statistics Denmark. The study was approved
by the local medical ethics committees (No. 11-087/99) and
the Danish Data Protection Agency (No. 2001-41-1018).
The following operational terms were used, adapted to
Danish administrative terminology (4). A foreign-born person
was any person born outside Denmark, while the term Somali
was applied to any person born in Somalia. An immigrant was
any foreign-born person legally admitted to Denmark who had
already settled in the country or was expected to do so. A refu-
gee was any person who had been granted refugee status by
the Danish authorities. An asylum-seeker was any person
wishing to be admitted to the country as a refugee but awaiting
decision on his or her application for refugee status. An illegal
immigrant was defined as any person whose entry, stay, or
work in the country was not permitted by the Danish authori-
ties. Illegal immigrants are considered rare in Denmark, and
no patient included in the study fell into this category. The
word “screening” was used in connection with any interven-
tions performed to discover Mycobacterium tuberculosis
infection suitable for early preventive or curative therapy, in a
person whose symptoms were not so severe as to cause him or
her to seek medical help. The term “medical evaluation” was
used in connection with interventions not specifically per-
formed to discover M. tuberculosis infection, e.g., general
health examinations.
Over the study period, the number of Somali immigrants in
Denmark increased considerably, from 743 in 1991 to 14,856
in 2000 (Table 1). Because of this sustained rise, the annual
increase in the number of Somali immigrants was classified as
net arrival in Denmark, without taking into account the small
numbers who were born, died, or left the country during the
study period. For example, at the beginning of 1992 and 1993,
respectively, 1,395 and 2,237 Somali immigrants were living
in Denmark, corresponding to a net arrival in 1992 of 2,237 –
1,395 = 842 persons (Table 1). To compare changes in num-
bers from year to year, the observation period for all Somali
immigrants included in the study in a given year was totaled as
person-observation years (Table 1). The Somali immigrants
entered Denmark at various times of the year; therefore, on
average each immigrant contributed only a half person-obser-
vation year in the calendar year of arrival. For example, in
1992 a total of 1,395 Somali immigrants were already living in
Denmark at the beginning of the year. They were observed
during the whole calendar year and thus accounted for 1,395
person-observation years. A further 842 Somali immigrants
arrived during 1992 and thus accounted for 842/2 = 421 per-
son-observation years, if an even distribution of arrivals is
Figure 2. Trends in number of reported cases of tuberculosis in Den-
mark over the last 15 years, by nationality.
Table 1. Number of Somalis in Denmark and cases of Somali immigrants reported as having tuberculosis, 1991–2000
Year
ab cd e




yrs (a + 1/2b) Reported casesc (no.)
Crude rated
(d as % of c) (95% CI)
1991 and earlier 743 652 1,069 NA NA
1992 1,395 842 1,816 20 1.1 (0.7 to 1.7) 
1993 2,237 1,552 3,013 41 1.4 (1.0 to 1.9) 
1994 3,789 1,491 4,535 92 2.0 (1.7 to 2.5)
1995 5,280 1,811 6,186 100 1.6 (1.3 to 2.0)
1996 7,091 2,794 8,488 114 1.3 (1.1 to 1.6)
1997 9,885 2,228 10,999 182 1.7 (1.4 to 1.9)
1998 12,113 1,422 12,824 167 1.3 (1.1 to 1.5)
1999 13,535 1,321 14,196 185 1.3 (1.1 to 1.5)
2000 14,856 NA NA NA NA
 aNumber of Somalis in Denmark by January 1.
bEstimated number of Somalis arriving in Denmark in 1 year. 
cSomalis reported as having tuberculosis (TB). 
dCrude incidence rate as % of the accumulated number of Somalis in Denmark; NA = not available; 95% CI = 95% confidence interval.Emerging Infectious Diseases  •  Vol. 8, No. 7, July 2002 681
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assumed throughout the year. Thus, the total number of Somali
immigrants in 1992 was 1,395 + 421 = 1,816 person-observa-
tion years (Table 1). Calendar years of arrival and diagnosis
were used because exact dates were not available.
In calculating incidences of TB in relation to duration of
residence in Denmark, we gave special attention to Somalis
reported as having TB during the period 1995–1999 (Table 2).
Each incidence was calculated from the number of Somalis
reported as having TB after a given number of years of resi-
dence in Denmark, divided by the total number of Somali
immigrants who had resided in Denmark for the same number
of years. In total, 748 Somalis were reported as having TB
from 1995 to 1999 inclusive. Of these, 84 persons were
excluded because of lack of information about their exact year
of arrival in Denmark, in addition to 45 persons who were
known to have arrived in 1991 or earlier (Table 2). Hence, we
were able to calculate the risk for developing TB in relation to
the average duration of residence in Denmark for 619 Somalis.
For example, 158 Somalis were reported as having TB during
their second calendar year of residence in Denmark, after an
average of 1 year’s residence in Denmark (Table 3). This num-
ber represents the sum of the 24 Somalis who arrived in 1994
and were reported in 1995, the 24 who arrived in 1995 and
were reported in 1996, the 58 who arrived in 1996 and were
reported in 1997, the 34 who arrived in 1997 and were
reported in 1998, and the 18 who arrived 1998 and were
reported in 1999 (Table 2). The TB incidence was then calcu-
lated by dividing by the person-observation years: the 158
Somalis who were diagnosed with TB during their second cal-
endar year of residence in Denmark were found among 9,746
person-observation years for persons who on average had
resided in Denmark for 1 year, giving an incidence of 158/
9,746 = 1.6% (Table 3).
For statistical analysis, 95% confidence intervals (CI) were
derived from the normal approximation to the binomial distri-
bution (Tables 1 and 3). The single p value given in the results
was calculated by the chi-square test. If one assumes a Poisson
distribution and an exponential decrease in incidence with
time, the half-time of the decline in the observed incidences
with time of residence was estimated (with 95% CI) by means
of SAS statistical software (GENMOD procedure; SAS Insti-
tute Inc., Cary, NC).
Results
Basic Cohort Data
From 1991 to 1999 in Denmark, 4,147 persons were
reported as having TB. Of reported patients, 57.5% (2,386/
4,147) were foreign-born, of whom 37.8% (901/2,386) were
Somali. For each year, 80%–91% of reported patients were
culture positive for M. tuberculosis. Of total culture-positive
patients, 74.7% had pulmonary TB with or without extrapul-
monary disease, and 25.3% had extrapulmonary disease only.
Foreign-born patients had a higher frequency of exclusively
extrapulmonary TB than Danish patients (45.6% vs. 16.6%;
p<0.001). Of Danish and foreign-born patients with culture-
positive pulmonary TB, 55.3% and 26.2%, respectively, had
sputum smears positive for acid-fast bacilli.
Trends in TB Incidence Related to 
Duration of Residence
The overall annual incidence rate for Somalis remained
fairly steady at 1.1%–2.0% (Table 1), but when duration of
residence in Denmark was taken into account, the incidence
gradually decreased from 2.0% (CI 1.7 to 2.5) during the year
of arrival to 0.7% (CI 0.4 to 1.2) during the sixth year of resi-
dence (Table 3; Figure 3). The only gradual decrease in inci-
dence rate was described by a simple exponential model with a
half-time of 5.7 (CI 4.0 to 9.7) years (Figure 3). Analysis of
Table 2. Somali immigrants in Denmark reported as having TB, 1995–




Year of diagnosis (no./yr)
1995 1996 1997 1998 1999 Total
1991 and 
earlier
1,395 8 5 10 8 14 45
1992 842 7 10 7 7 13 44
1993 1,552 30 13 10 18 10 81
1994 1,491 24 22 19 22 20 107
1995 1,811 17 24 29 29 21 120
1996 2,794 - 28 58 31 27 144
1997 2,228 - - 21 34 19 74
1998 1,422 - - - 10 18 28
1999 1,321 - - - - 21 21
Unknown yr of arrival (%) 14 12 28 8 22 84 (11.2) 
Total TBa (%) 100 114 182 167 185 748 
(100.0)
aTotal number of Somali immigrants reported as having tuberculosis (TB).
Table 3. Risk for tuberculosis (TB) related to duration of residence in 














1/2b 4,788b 97 2.0 (1.7 to 2.5) 1.0b
1 9,746 158 1.6 (1.4 to 1.9) 2.6 
2 9,876 131 1.3 (1.1 to 1.6) 3.9
3 8,490 95 1.1 (0.9 to 1.4) 5.0
4 5,696 63  1.1 (0.9 to 1.4) 6.1 
5 3,885 45 1.2 (0.9 to 1.6) 7.3
6 2,394 17 0.7 (0.4 to 1.2) 8.0
7 842 13 1.5 (0.9 to 2.7) 9.5
aAverage duration of residence in Denmark
bPerson-observation years and cumulated incidence only “counts half” in year after 
arrival (see Methods); 95% CI, 95% confidence interval.RESEARCH
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residuals plotted against duration of residence, year of arrival,
year of diagnosis, and person-observation years showed no
obvious deviation from a simple exponential model during the
first years of residence. During the seventh year of residence,
the incidence increased to 1.5% (CI 0.9 to 2.7); however, as
seen from the wide CI, this figure is subject to considerable
uncertainty. Only 842 Somali immigrants, of whom 13 were
reported as having TB, had been living in Denmark long
enough to be eligible for observation during their seventh year
of residence (Table 3). Overall, 9.5% of all Somalis who
arrived in Denmark were diagnosed with TB  during their first
7 years of residence (Table 3).
Discussion
TB after Arrival in a Low-Incidence Country
Our data show that the initial incidence of TB in Somalis
entering Denmark was high, and more importantly, that this
high initial incidence declined only gradually, at first in an
exponential manner, in the 7 years after arrival. The incidence
of TB in Somalis in Denmark is higher than in any other for-
eign-born population group in the country (19,20) and is com-
parable with or even higher than the estimated incidence in
Somalia (21). During their first 2 years of residence in Den-
mark, 3.9% of all Somalis were diagnosed with TB, and after 7
years, 9.5% were reported as having TB (Table 3). The exact
reasons for the extraordinarily high and only slowly declining
incidence of TB in Somalis in Denmark remain unknown, but
some theoretical possibilities are discussed in this section. 
Epidemiologically, the most important potential impact of
excess TB cases due to immigrants from an area of high inci-
dence would be an increase in the rate of transmission in the
recipient country of low incidence (22). However, the number
of reported TB cases in the Danish-born population has not yet
shown any detectable increase in parallel with the increase in
the cases in the foreign-born population (Figure 2). Moreover,
a nationwide study of M. tuberculosis DNA patterns from
3,320 TB patients in Denmark recently indicated that TB due
to transmission among Somalis in Denmark was limited, and
transmission between Somalis and Danes was almost nonex-
istent (6). Recent M. tuberculosis transmission among the
Somalis in Denmark cannot explain the high and only gradu-
ally declining incidence of the disease after arrival; further-
more, the Somalis in Denmark have not substantially
increased their risk for TB infection, as they are diagnosed and
treated promptly.
In combination with a high prevalence of dormant M.
tuberculosis infection, impairment of the immune system (e.g.,
as a result of HIV infection) could reactivate latent disease
(23,24). Indeed, M. tuberculosis bacteria in immigrants from
high-incidence areas may constitute a pool from which active
TB could develop. Without taking BCG vaccination status into
account, tuberculin skin testing of 300 Somalis in Denmark
has indicated that 80%–90% of all adults (16–49 years of age)
and 25% of all children were infected with M. tuberculosis at
the time of arrival (unpub. data). However, only 1–2 Somali
TB patients are found to be HIV positive every year. In addi-
tion, four studies in Somalia reported a very low prevalence of
HIV infection, even among prostitutes attending a clinic for
sexually transmitted diseases in the capital Mogadishu (21,25–
27). At present, HIV infection does not seem to play an impor-
tant role in the development of TB in Somalis.
The mechanisms behind the pattern of incidence of TB in
Somalis in Denmark merit further exploration. One of the
principal hypotheses is that the immigrant population contains
many cases of latent infection with M. tuberculosis that later
produce overt disease (28). Factors that could promote this
reactivation, which should be identified and examined, include
vitamin deficiencies, genetic constitution, and immune
defects. In the preantibiotic era, the risk of reactivation of TB
after recovery was extraordinarily high: annual relapse rates
were 4.4% during the first 5 years and 1.6% during the next 5
years (2). The situation in Somalia and the refugee camps from
which the immigrants have come may resemble the preantibi-
otic era in the high number of relapses and reactivations now
being observed. In addition, many cases of TB may not have
been identified in the refugee camps, or if they were diag-
nosed, patients may not have received proper treatment
because of lack of resources (16). The discovery of such cases
during screening on arrival in Denmark could explain the high
initial incidence and why this rate could exceed the estimated
rate in Somalia, where cases may remain unrecorded (21).
Implications for Policy of On-Arrival–Only Screening
Only a few studies have described the trend in TB inci-
dence in immigrants over the years after their arrival from an
area of high incidence (13–17). Three of these studies were
restricted to immigrants arriving from Asia (14–16), and two
covered only a short period of observation (16,17). The gen-
eral finding was of a prompt decline in incidence during the
Figure 3. Trend in the incidence of tuberculosis in Somali immigrants in
Denmark, by duration of residence. The dotted line indicates the esti-
mated incidence curve and t(1/2) the corresponding half-time, with con-
fidence interval.Emerging Infectious Diseases  •  Vol. 8, No. 7, July 2002 683
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first few years of residence in the receiving country, although
two studies reported an increased TB risk many years after
arrival, as we observed for the Somalis in Denmark (13,16).
The observation of a prompt decline in incidence has had a
major influence on the countermeasures taken to prevent and
control the disease in low-incidence countries. Nearly all low-
incidence countries have implemented programs in which
immigrants are screened only at the time of arrival (4,12): in
1994 20 of 23 European countries followed this practice (4). 
In Denmark, all refugees and asylum seekers are encour-
aged to have a general medical evaluation (not specific for TB)
only at the time of arrival in the country. Those who do not
arrive as refugees or asylum seekers do not undergo systematic
medical evaluations but are entitled to contact the free public
health-care system on their own initiative. After the initial
medical evaluation, the immigrants, refugees, and asylum
seekers in Denmark, as in most other low-incidence countries,
are covered by the national TB program, which is based on
passive case-finding and treatment of active cases, combined
with contact tracing (29). This program involves chest x-ray
examination if pulmonary symptoms persist for >6 weeks,
examination for M. tuberculosis if chest x-ray is suggestive of
TB, examination by chest x-ray every 6 months for 3 years in
tuberculin-positive subjects who have had recent exposure to a
smear-positive TB patient, examination for M. tuberculosis
from extrapulmonary sites if symptoms indicate TB, free four-
drug short-course treatment regimens for TB patients, and pre-
ventive chemotherapy only for children <7 years of age whose
tuberculin skin test is positive (29).
The gradually declining incidence in the years after arrival
observed for Somalis in Denmark, persons of different nation-
alities in the United States (13), and Asians in Canada (16)
seriously challenges the adequacy of the policy of screening
only on arrival. National TB programs in low-incidence coun-
tries should be expanded to include surveillance of trends in
the incidence of TB in specific immigrant populations during
subsequent years as well. If a gradual decline similar to that in
the Somalis in Denmark and Asians in Canada is observed, the
present policy of screening only on arrival needs to be revised
and refocused. Such revision would probably include as an
important feature the institution of voluntary regular health
examinations, at reasonable intervals after arrival, for specifi-
cally identified high-risk immigrant groups, as the risk may
persist for many years. Intervention needs to be an ongoing
process that includes both latent M. tuberculosis infection as
well as active TB. 
Another way of preventing TB in high-risk groups such as
the Somalis in Denmark could be preventive chemotherapy,
i.e., treatment of persons with subclinical M. tuberculosis
infection. Several controlled studies have documented the
effectiveness of such a strategy in preventing progression to
TB or reactivation of disease on an individual basis (30), but
the effectiveness of preventive chemotherapy administered to
population groups needs further evaluation (22,31). The com-
pliance of participants is crucial for obtaining satisfactory
results (30). For instance, a large meta-analysis showed that
only 60.5% of 1,084,760 persons completed preventive ther-
apy (32). If preventive therapy is used indiscriminately, a large
number of infected persons would have to be treated to prevent
the occurrence of a single case of TB (30), and all those treated
would be at risk of side effects from the medication (32). How-
ever, preventive therapy may decrease illness for the 9.5% of
Somalis who have TB during the first 7 years of residence in
Denmark, if the medication is efficiently distributed to the
Somalis with latent infection.
Focused Intervention: Key to Future Control?
As TB declines in low-incidence countries, M. tuberculosis
transmission is markedly reduced, and most cases arise in per-
sons who have previously been infected (3). Most cases of TB
infection have been acquired in the same country, as has been
observed for most older Danish-born TB patients, or have
been acquired in another country where TB is still actively
transmitted and subsequently been imported, as observed in
the Somalis in Denmark (6). Thus, in low-incidence countries
TB has increasingly come to be a disease of specific subgroups
of the population (22). This trend provides an opportunity for
focused intervention, the success of which will depend on cor-
rectly identifying the population groups at risk. Because of the
considerable geographic variations in TB in immigrants from
different countries and different trends in incidence after
arrival in various host countries, approaches to controlling and
preventing TB should be tailored to the specific foreign-born
populations at risk. Control and elimination strategies should
be focused on diminishing the incidence and prevalence of
latent infection to reduce the pool of TB infection from which
future cases of TB will emanate. This goal can be accom-
plished by two approaches: first, to reduce the incidence of
new TB infection and thereby limit the growth of the pool and
second, to reduce its prevalence (33). To arrest the chain of
transmission, the risk of new generations becoming infected
must be minimized by the early identification and curative
treatment of newly emerging infective sources. Furthermore,
newly infected persons must be prevented from progressing to
overt disease; this approach reduces the number of cases
caused by recent transmission (3). Our study also underlines
the importance of transition from latent infection to active dis-
ease. If we seek to control the rates of TB in immigrants arriv-
ing from areas of high incidence, the success of our control
measures will increasingly depend on reducing the impact of
TB in immigrants by arresting the transition from latent to
active disease. However, the global perspective of TB should
also be kept in mind: the impact of disease falls principally on
developing nations, where 95% of all cases and 98% of deaths
due to TB occur (34). Intervention in such high-incidence
areas, in addition to intervention in the low-incidence coun-
tries, is still crucial for the elimination of TB.RESEARCH
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